Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiyuki Sakata

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 15, 2010
[C1-inhibitor]Toshiyuki Sakata
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 22, 2005
[Thrombin, antithrombin, thrombin-antithrombin complex (TAT)]Toshiyuki Sakata
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 23, 2005
[Immunologic tests: C1-inhibitor]Toshiyuki Sakata
Rinsho Byori. the Japanese Journal of Clinical Pathology|May 16, 2013
[New stream for the measurement of anti-platelet factor 4/heparin antibodies]Toshiyuki Sakata
Atherosclerosis|December 3, 2010
Antiplatelet therapy effectively reduces plasma plasminogen activator inhibitor-1 levelsToshiyuki Sakata, Kazuomi Kario
Thrombosis and Haemostasis|May 6, 2006
Increased plasma plasminogen activator inhibitor-1 levels caused by additional aspirin treatmentToshiyuki Sakata, Kazuomi Kario
International Journal of Hematology|May 25, 2006
Genetic risk factors for deep vein thrombosis among Japanese: importance of protein S K196E mutationToshiyuki Miyata, Rina Kimura, Yoshihiro Kokubo, et al.
Thrombosis Research|February 15, 2003
Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complicationMasahiro Yasaka, Toshiyuki Sakata, Kazuo Minematsu, et al.
Thrombosis Research|March 29, 2005
Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulationMasahiro Yasaka, Toshiyuki Sakata, Hiroaki Naritomi, et al.
Thrombosis and Haemostasis|February 8, 2003
Predisposing factors for enlargement of intracerebral hemorrhage in patients treated with warfarinMasahiro Yasaka, Kazuo Minematsu, Hiroaki Naritomi, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 15, 2010
[C1-inhibitor]Toshiyuki Sakata
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 22, 2005
[Thrombin, antithrombin, thrombin-antithrombin complex (TAT)]Toshiyuki Sakata
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 23, 2005
[Immunologic tests: C1-inhibitor]Toshiyuki Sakata
Rinsho Byori. the Japanese Journal of Clinical Pathology|May 16, 2013
[New stream for the measurement of anti-platelet factor 4/heparin antibodies]Toshiyuki Sakata
Atherosclerosis|December 3, 2010
Antiplatelet therapy effectively reduces plasma plasminogen activator inhibitor-1 levelsToshiyuki Sakata, Kazuomi Kario
Thrombosis and Haemostasis|May 6, 2006
Increased plasma plasminogen activator inhibitor-1 levels caused by additional aspirin treatmentToshiyuki Sakata, Kazuomi Kario
International Journal of Hematology|May 25, 2006
Genetic risk factors for deep vein thrombosis among Japanese: importance of protein S K196E mutationToshiyuki Miyata, Rina Kimura, Yoshihiro Kokubo, et al.
Thrombosis Research|February 15, 2003
Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complicationMasahiro Yasaka, Toshiyuki Sakata, Kazuo Minematsu, et al.
Thrombosis Research|March 29, 2005
Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulationMasahiro Yasaka, Toshiyuki Sakata, Hiroaki Naritomi, et al.
Thrombosis and Haemostasis|February 8, 2003
Predisposing factors for enlargement of intracerebral hemorrhage in patients treated with warfarinMasahiro Yasaka, Kazuo Minematsu, Hiroaki Naritomi, et al.
Pageof 3